Market Size (2014)
2014
$4.09B
Healthcare
Amblyopia Market
By Segment, By Region, And Segment Forecasts, 2014 – 2023
Vertical: HealthcareBase Year: 201611 Sections
Executive Summary
Amblyopia Market — Snapshot
Projected (2023)
2023
$5.62B
CAGR (2014–2023)
3.6%
3.6%Key Players
110+
This report covers Amblyopia Market with forecasts from 2014 to 2023. 110 key companies are profiled.
Key Insight
The Amblyopia Market market is projected to grow at a CAGR of 3.6% from 2014 to 2023.
Market Performance Trend
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Scope & Coverage
What this report covers
- Geographic Coverage: This analysis covers 5 regions: Middle East and Africa, North America, Asia Pacific, Europe, South America.
- Market Segmentation: The market is analyzed across 4 segments: Strabismus Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, Reverse Amblyopia. Forecasts are provided for each segment from 2014 to 2023.
- Competitive Landscape: 110 leading companies are profiled, covering market positioning, strategies, and recent developments.
Market Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Overview
Amblyopia Market — Growth Trajectory
Amblyopia is an eye disorder which leads to decreased vision in one or both the eyes due to suppressed input from the brain. The most common cause of amblyopia is a refractive error in one or both eyes or it might even occur due to muscle imbalance. The other cause of amblyopia is if the infant is born with cataract, which causes cloudy images. There are four types of amblyopia, namely, Strabismus Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, and Reverse Amblyopia.
The global prevalence rate of Amblyopia is 2 to 3% of the infant population.
Amblyopia Market — Growth Trajectory
Strabismus Amblyopia
Refractive Amblyopia
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size Trend (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Dimensions
How this market is segmented
- Type Type is broken down into: Strabismus Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, Reverse Amblyopia.
- Treatment Treatment is broken down into: Eye Patches, Glasses, Video game, Others (Surgery & Vision therapy), Ophthalmic Drops & Ointments.
- End User End User is broken down into: Hospitals & Pharmacies, Ophthalmic Clinics.
Geographic Analysis
Regional market breakdown
- Middle East and Africa Middle East and Africa market size reached $368.51M in 2014 and is projected to reach $505.61M by 2023, growing at a CAGR of 3.6%.
- North America North America market size reached $1.23B in 2014 and is projected to reach $1.63B by 2023, growing at a CAGR of 3.2%.
- Asia Pacific Asia Pacific market size reached $941.74M in 2014 and is projected to reach $1.36B by 2023, growing at a CAGR of 4.1%.
- Europe Europe market size reached $1.22B in 2014 and is projected to reach $1.71B by 2023, growing at a CAGR of 3.9%.
- South America South America market size reached $338.86M in 2014 and is projected to reach $415.35M by 2023, growing at a CAGR of 2.3%.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Methodology
Amblyopia Market — How We Researched This Market
This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2016
Historical Period
2014 – 2016
Forecast Period
2016 – 2023
Primary Interviews
150+
Research Process
Historical data (2014–2016) and forecast period (2016–2023)
1
Problem Definition
- Market scoping
- Objective setting
- Framework design
2
Secondary Research
- Literature review
- Data mining
- Trend analysis
3
Primary Research
- Expert interviews
- Field visits
- Surveys
4
Data Analysis
- Quantitative modeling
- Statistical testing
- Validation
5
Insights & Reporting
- Synthesis
- Recommendations
- Visualization
Research Depth
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Historical vs. Forecast Data
Historical (observed)
Forecast (modelled)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansCompetitive Landscape & Porter's Five Forces
Amblyopia Market — Competitive Analysis
Bargaining Power of Suppliers
Bargaining power of suppliers in the amblyopia market is low to medium. The number of suppliers in the market is high which gives plenty of options to drug manufacturers for material sourcing which is required for the production of the various drugs, thus leaving suppliers with medium bargaining power. Another, factor affecting the bargaining power of suppliers is the supplier switching cost for buyers owing to the presence of a moderate number of raw material suppliers in the market. On the other hand, only a moderate number of viable raw material substitutes are available, which further boosts the bargaining power of suppliers in the market. In addition, low chances of forward integration decreases the bargaining power of suppliers.
Bargaining Power of Buyers
The bargaining power of buyers is moderate to high in the global amblyopia market. The market has a large number of buyers comprising of various amblyopia treatment drugs. The buyers of amblyopia in global market are highly inclined towards brand identity. Moreover the buyers can exert moderate to high pressure on the drugs manufacturing companies as some of the companies provides their product very costly. Hence, presence of large number of companies and huge number of products the bargaining power of suppliers tend to be moderate to high. On the other hand, the increasing demand for laser treatment may reduce the bargaining power of buyers.
Threat of New Entrants
Threat of new entrants is high in the global amblyopia market. Prevalence of eye strokes and eye diseases is increasing significantly which has increase the demand for new drugs. Available drugs did show long term effects and thus manufactures are focusing on research and development in some cases to avoid surgical procedure. Moreover, increasing geriatric population and funding is influencing many of the start-up to take keen interest in the field of research & development. Introduction of new drugs requires a long time clinical trial and a huge capital. This is the reason that there are medium possibilities of new entrants in the market.
Threat of Substitutes
Threat of substitutes in the global amblyopia market is medium to high. There are number of substitute’s treatment methods that pose a moderate to high threat in the global amblyopia market. In addition to this, introduction of generic drugs and increasing competition in the market has increase the availability of the products. Thus, the high degree of switching cost increases the threat of substitutes.
Intensity of Rivalry
The degree of competition in the global amblyopia market is medium to high. New amblyopia treatment products that use to be launched into the market needs less of approval. People are more inclined towards brand identity. However, increasing government support and availability of funding has encouraged many new start-ups. To compete with multinational players, new and small companies are reducing cost of their products.
Quantitative Analysis
Regional Breakdown
Regional market breakdown for Amblyopia Market.
Regional Market Size (USD Mn)
Market estimates by geography (2023)
USD Mn
InsightEurope leads with $1.71B by 2023, while Asia Pacific is projected to grow fastest at a 4.1% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRegional Market Data
| REGION | 2014 | 2016 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $368.51M | $435.54M | $505.61M | 3.6% | 9% |
| North America | $1.23B | $1.43B | $1.63B | 3.2% | 29% |
| Asia Pacific | $941.74M | $1.14B | $1.36B | 4.1% | 24% |
| Europe | $1.22B | $1.46B | $1.71B | 3.9% | 30% |
| South America | $338.86M | $376.61M | $415.35M | 2.3% | 7% |
| Total | $4.09B | $4.84B | $5.62B | 3.6% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSegment Revenue (2023)
Strabismus Amblyopia
Refractive Amblyopia
Deprivation Amblyopia
Reverse Amblyopia
0687137420612748
Segment Market Share
- Strabismus Amblyopia44%
- Refractive Amblyopia31%
- Deprivation Amblyopia15%
- Reverse Amblyopia10%
Total Market Size
$5.62B
Market by Segment (2023)
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Strabismus Amblyopia | $2.50B | 3.6% | 85% |
| Refractive Amblyopia | $1.71B | 3.6% | 85% |
| Deprivation Amblyopia | $850.30M | 3.6% | 81% |
| Reverse Amblyopia | $555.68M | 3.6% | 88% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansEmpower your Business
with InsightsSave over 20% on
with Insights
Save over 20% on
Annual Subscription
See plans for professionals or small and medium businesses.
Analytics
Amblyopia Market — Key Findings
Analytical insights on Amblyopia Market covering market dynamics, competitive landscape, and strategic outlook.
Key Analytical Findings
The Amblyopia Market market is projected to reach $5.62B by 2023, growing at 3.6% CAGR. The Strabismus Amblyopia segment holds the largest share.
Market Dynamics
Amblyopia commonly known as lazy eye, is a vision impairment disorder. It is one of the leading cause of unilateral vision loss. It requires to be treated in early childhood, which otherwise can be less successful in later age. Amblyopia can be caused by imbalance in the positioning of the two eyes, and difference of sharpness in vision between the eyes. Amblyopia market is driven by growing incidence of ophthalmological disorders such as cataracts, macular degeneration, glaucoma, and refractive errors.
Market Drivers
Facts & Information
According to reports published by the United Kingdom Statistics Authority, in 2015, around 15,900 people were registered as visually impairedAdditionally; 1,243 patients were newly registered as sight impaired in 2015Similarly, according to the American Academy of Ophthalmology, around 48,229 corneal transplants were performed in the U.S. as of 2014According to the Journal of Ophthalmology, as of 2014 there were around 28 million visually impaired people in the European regionAccording to the WHO, around 285 million people were visually impaired in 2014 and approximately over 24.4 million American aged 40 and above had cataract
Interpretation & Impact
Prevalence of ophthalmological disorders is growing at an alarming rate worldwide. Rising aging population and changing lifestyle are promoting the rising prevalence of ophthalmological disorders. Over the past decade, prevalence of ophthalmological disorders has risen faster in low & middle income countries.
Growth Enhancement Factor
Rising prevalence of ophthalmological diseases and its related complications directly promotes the growth of Amblyopia market.
Conclusion
Ophthalmological ailments represents a serious challenge to the health system worldwide as it isn’t only a huge health burden but an economic burden.
Market Opportunities
Facts & Information
The prevalence of amblyopia in developing countries is risingAccording to NCBI, the prevalence of amblyopia in India is estimated to be 1.1%, this prevalence is expected to prove a huge scope for amblyopia market in developing countriesAdditionally, lack of presence of market players in developing countries leaves a huge scope for market players to explore the developing countries
Interpretation & Impact
Developing countries being an untapped market leaves huge scope for amblyopia market.
Growth Enhancement Factor
Acceptance and efficiency in the initial years will be a factor that is likely to hamper the market growth.
Conclusion
Exploring developing countries will prove to be a gain for amblyopia market.
Market Restraints
Facts & Information
Lack of awareness and knowledge regarding amblyopia and its timely diagnosis has been the cause of significant visual impairment in later adulthoodAccording to various studies by NCBI, the prevalence of amblyopia in school children is stated to be around 3.3% in the Americas, and the prevalence of amblyopia in India was estimated to be around 1.1%This rising prevalence of amblyopia in school children is driving the growth of the market. However, the lack of awareness and knowledge among the parents to detect amblyopia among their children is hampering the growth of the market
Interpretation & Impact
Lack of knowledge in terms of amblyopia and its symptoms is deterrent to the growth of the market.
Growth Restraining Factor
Lack of awareness and knowledge is hampering the growth of amblyopia market.
Conclusion
Lack of knowledge leading to loss in timely management of amblyopia treatment is likely to hamper the growth of the global amblyopia market.
Strategic Outlook and Future Directions
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Market Value by Segment (2023)
Value (USD Mn)
Strabismus Amblyopia
Refractive Amblyopia
Deprivation Amblyopia
Reverse Amblyopia
Companies
Key companies profiled in Amblyopia Market
Profiles of 110 companies operating in the Amblyopia Market market, including revenue, employee count, and market positioning where available.
Showing 110 of 110 companies
Hilco Visi
Hilco Vision
Healthcare
Company Headquater: Massachusetts, U.S. Company Working: Company is a gloabal leader in eyewear and eye care solutions to customers. Established: 1956
RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Fresnel Pr
Fresnel Prism and Lens Co.
Healthcare
Company Headquater: Minnesota U.S. Company Working: Fresnel Prism and Lens Co.has focused on providing diagnostic and therapeutic treatment related to eyecare. Established: 2008
RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Krafty Eye
Krafty Eye Patches.
Healthcare
Company Headquater San Diego, California Company Working The Company design, develop, and offers Latex free, Hypo-Allergenic Orthoptic eye patches . Established 2010
RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
HOYA Corpo
HOYA Corporation
Healthcare
Company Headquater: Japan Company Working: The company provides unique and competitive products and services to provide a wide range of eye care products. Established: 1941
Revenue$3.8B
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Carl Zeiss
Carl Zeiss AG
Healthcare
Company Headquarter: Oberkochen, Germany Workforce: 26,000+ employees Founded:1996 Company Working: The company is one of the leading manufacturers of optical systems, industrial measurements, and medical devices
Revenue$5.5B
Employees26,000
Market CapN/A
Founded1995
United States, North America
Novartis A
Novartis AG.
Healthcare
Company Headquarters: Basel, Switzerland Founded: 1996 Workforce: 1, 26,000 Company Working: Novartis AG was established in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis AG and its predecessor companies have a rich history of developing innovative new products that trace back to more than 250 years. The company focuses on the development and marketing of new products that contribute to human progress through advances in science and health. It provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardio-metabolic, and established medicine products.
Revenue$42.3B
Employees26,000
Market CapN/A
Founded1995
Basel, Switzerland
Page 1 of 19
…
Go to page
Powering the world's best teams.
From next-gen startups to established enterprises.
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Amblyopia Market
Starting from
$4,950